Skip to main content
BELLUSCURA PLC logo

BELLUSCURA PLC — Investor Relations & Filings

Ticker · BELL ISIN · GB00BD3B8Z11 LEI · 213800BRJQZE56XBPW94 IL Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2023-01-27 Regulatory Filings
Country GB United Kingdom
Listing IL BELL

About BELLUSCURA PLC

https://belluscura.com/

Belluscura PLC is a medical device company specializing in the development and commercialization of advanced oxygen enrichment technologies. The company's primary focus is on manufacturing lightweight, portable oxygen concentrators (POCs) designed to improve the quality of life for individuals requiring supplemental oxygen therapy. Its product portfolio is headlined by the FDA-cleared X-PLOR® and the DISCOV-R™ models. These devices utilize proprietary, patented technologies such as ModulAir™ and an Airgonomical™ design to deliver high oxygen output in a compact form factor, offering an alternative to traditional, cumbersome oxygen tanks and promoting user mobility and independence.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' multiple times. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short announcement related to trading mechanics rather than a comprehensive financial report (like 10-K or IR) or a management change (MANG). Since it is a general regulatory announcement disseminated via the RNS system and does not fit into the more specific categories like DIV, DIRS, or ER, the most appropriate classification is the general regulatory filing category.
2023-01-27 English
Placing of Unsecured Convertible Loan Notes
Capital/Financing Update Classification · 98% confidence The document is an official announcement released via RNS (Regulatory News Service), indicated by the 'RNS Number' header and the use of the National Storage Mechanism. The content details a significant corporate financing event: a conditional firm placing of Convertible Loan Notes amounting to $5.0 million, along with a Broker Option for an additional $5.0 million. It also mentions related party transactions and the need for shareholder approval via a General Meeting (AGM/EGM related activity). Since the core subject is raising capital through debt instruments (Loan Notes), it directly falls under the 'Capital/Financing Update' category. Although it is an announcement, the substance is the financing deal itself, not just the announcement of a report, making 'CAP' more specific than 'RPA' or 'RNS'.
2023-01-27 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1931 characters) and contains the header 'RNS Number : 7354N'. It announces a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement disseminated via the RNS system, rather than a comprehensive report like an Annual Report (10-K) or an Earnings Release (ER). Since it is a specific regulatory notice that doesn't fit the other defined categories (like DIRS, DIV, or MANG), the most appropriate classification is the general regulatory filing fallback category.
2023-01-24 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1914 characters) and announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange, referencing 'RNS Number' and stating that RNS is approved by the Financial Conduct Authority (FCA). This is a brief, specific regulatory announcement that does not fit the definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (AGM-R, DVA). Since it is a direct, non-standard regulatory notification provided via the RNS service, the most appropriate classification is the general regulatory filing fallback category.
2023-01-24 English
Belluscura appoints Senior VP of Global Sales
Board/Management Information Classification · 98% confidence The document begins with an 'RNS Number' and is dated 16 January 2023. The content announces the appointment of a new Senior Vice President of Global Sales. This type of announcement, concerning management changes, directly aligns with the definition for Board/Management Information (MANG). Although it is distributed via RNS, the specific content is about management, making MANG the most precise classification over the general RNS code. The document length (4616 chars) is substantial enough to be the primary announcement, not just a placeholder for a report.
2023-01-16 English
Year-end Trading Update
Earnings Release Classification · 95% confidence The document is identified by the RNS Number (6000M) and explicitly states it is being distributed via a Regulatory Information Service (RNS). The content is a 'Year-end trading update' for the period ended 31 December 2022, providing key financial highlights (Adjusted EBITDA loss, cash balances) and operational progress. This format—a brief update on recent performance released via an official regulatory channel—most closely aligns with an Earnings Release (ER), which typically contains key highlights before a full report. However, since it is explicitly distributed via RNS and contains general business updates and forward-looking statements rather than just core quarterly figures, and given the context of RNS distribution, it fits well into the general regulatory announcement category. Since it is a trading update and not a full quarterly report (IR) or annual report (10-K), and it is distributed via RNS, the most appropriate classification is RNS, as it is a general regulatory announcement that doesn't perfectly match ER (which is usually more structured around P&L/Balance Sheet metrics) or MDA (which is usually a more detailed management discussion accompanying a formal filing). Given the RNS header and the nature of the announcement, RNS is the safest fit, although ER is a close second if the focus is purely on the financial update aspect. FY 2022
2023-01-13 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.